Strategic Operational Drivers
Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.
-
Achieved record cannabis harvest yields at Delta facilities through the first half of 2026, including the first harvest from the Delta 2 expansion phase.
-
Realized nearly 10 percentage points of year-over-year gross margin expansion, attributed to record yields, greater operating efficiencies, and a favorable sales mix.
-
Leveraged the world's largest EU GMP certified cannabis facility to drive a 74% year-over-year increase in international export sales.
-
Gained top 10 market share in all major Canadian convenience product categories, including vapes and infused pre-rolls, through entirely organic growth.
-
Maintained a competitive advantage in Germany by holding 4 of the top 10 market share strains and achieving the widest pharmacy distribution of any cultivator.
-
Successfully transitioned the legacy produce business to a private model, resulting in the fifth consecutive quarter of positive net income and EPS.
-
Optimized the cannabis supply chain by significantly improving the sales mix of higher-margin EU GMP certified products over GACP products.
Growth Outlook and Strategic Initiatives
-
Commencing the second half of the Delta 2 expansion on September 1st, targeting an incremental 15 metric tons of production in 2026 and 25 tons in 2027.
-
Projecting a full 40 metric ton incremental run rate by Q3 2027, bringing total annualized Delta production to approximately 160 metric tons by 2028.
-
Expecting the Groningen facility in the Netherlands to ramp to full production capacity by the end of Q1 2027, positioning the segment for step-function growth.
-
Anticipating entry into new European jurisdictions in the second half of 2026 while monitoring potential expansion of the Netherlands pilot program.
-
Forecasting stronger free cash flow and a growing cash balance for the remainder of the year as capital expenditures for major expansions are nearly complete.
Financial and Regulatory Context
-
Reported a one-time $4.3 million vendor settlement in the prior year's results, which impacted year-over-year EBITDA and net income comparisons.
-
Updated transfer pricing policies following the produce business sale, resulting in a higher allocation of corporate expenses directly to the cannabis segment.
-
Paid $17 million in Canadian income taxes during the first half of 2026, reflecting a full year and a half of obligations and a shift to sustainable profitability.
-
Completed a $15 million equity placement with U.S. institutional investors to strengthen the balance sheet and increase institutional ownership.
Q&A Insights
Competitive sustainability of EU GMP exports versus potential U.S. entrants
One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here.
-
Management emphasized that maintaining EU GMP certification is significantly more difficult and costly than initial certification, serving as a high barrier to entry.
-
Large-scale, efficient operations are required to offset the increased cost of production associated with pharmaceutical-grade compliance.
-
The company remains open to using its Delta 1 facility for future U.S. exports depending on regulatory shifts.
Long-term EBITDA margin aspirations and pricing pressure
-
Targeting long-term gross margins of 30% to 40%, with EBITDA margins potentially reaching the mid-20s through economies of scale.
-
Management noted that while Canadian pricing is plateauing, international EU GMP pricing remains strong and less susceptible to the pressures facing non-compliant products.
Vertical integration strategy and route to market in Europe
-
Confirmed plans to become more vertically integrated in the European theater, moving beyond the current B2B/FOB model to include branded products.
-
Management indicated they have avoided 'ridiculous valuations' for downstream assets in the past but see integration as a key future step as they scale.
Texas licensing status and entry strategy
-
Management clarified that the 12 provisional licenses issued in Texas are not final, and the door is not shut for Village Farms to secure a license.
-
Stated a firm intention to be in the Texas market but declined to provide specific details on the current pursuit of conditional licenses.
